Drug Information
General Information | ||||||
---|---|---|---|---|---|---|
Drug ID |
DR00485
|
|||||
Drug Name |
Indocyanine green
|
|||||
Synonyms |
3599-32-4; AC1L2DMU; Cardiogreen; F9995-0163; GTPL4844; Indocyanine green; KS-00000YFZ; MOLI001001; sodium 4-(2-((1E,3E,5E,7E)-7-(1,1-dimethyl-3-(4-sulfonatobutyl)-1H-benzo[e]indol-2(3H)-ylidene)hepta-1,3,5-trienyl)-1,1-dimethyl-1H-benzo[e]indolium-3-yl)butane-1-sulfonate; sodium 4-[2-[(1E,3E,5E,7Z)-7-[1,1-dimethyl-3-(4-sulfonatobutyl)benzo[e]indol-2-ylidene]hepta-1,3,5-trienyl]-1,1-dimethylbenzo[e]indol-3-ium-3-yl]butane-1-sulfonate
|
|||||
Drug Type |
Small molecular drug
|
|||||
Indication | Gastrointestinal disease [ICD11: DE2Z] | Approved | [1] | |||
Structure |
|
|||||
3D MOL | 2D MOL | |||||
Formula |
C43H47N2NaO6S2
|
|||||
Canonical SMILES |
CC1(C(=[N+](C2=C1C3=CC=CC=C3C=C2)CCCCS(=O)(=O)[O-])C=CC=CC=CC=C4C(C5=C(N4CCCCS(=O)(=O)[O-])C=CC6=CC=CC=C65)(C)C)C.[Na+]
|
|||||
InChI |
InChI=1S/C43H48N2O6S2.Na/c1-42(2)38(44(28-14-16-30-52(46,47)48)36-26-24-32-18-10-12-20-34(32)40(36)42)22-8-6-5-7-9-23-39-43(3,4)41-35-21-13-11-19-33(35)25-27-37(41)45(39)29-15-17-31-53(49,50)51;/h5-13,18-27H,14-17,28-31H2,1-4H3,(H-,46,47,48,49,50,51);/q;+1/p-1
|
|||||
InChIKey |
MOFVSTNWEDAEEK-UHFFFAOYSA-M
|
|||||
CAS Number |
CAS 3599-32-4
|
|||||
Pharmaceutical Properties | Molecular Weight | 775 | Topological Polar Surface Area | 137 | ||
Heavy Atom Count | 54 | Rotatable Bond Count | 12 | |||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 7 | |||
PubChem CID | ||||||
PubChem SID | ||||||
TTD Drug ID | ||||||
DT(s) Transporting This Drug | OATP1B3 | Transporter Info | Organic anion transporting polypeptide 1B3 | Substrate | [2] | |
References | ||||||
1 | Indocyanine green was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019) | |||||
2 | Primovist, Eovist: what to expect? J Hepatol. 2012 Aug;57(2):421-9. |
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.